1. Expression profiling reveals transcriptional regulation by Fbxw7/mTOR pathway in radiation-induced mouse thymic lymphomas
   Antoine M. Snijders et al, 2015, Oncotarget CrossRef
2. Construction and validation of a novel ferroptosis-related signature for evaluating prognosis and immune microenvironment in ovarian cancer
   Jiani Yang et al, 2023, Frontiers in Genetics CrossRef
3. Increased expression of the gene encoding stearoyl-CoA desaturase 1 in human bladder cancer
   M. Presler et al, 2018, Molecular and Cellular Biochemistry CrossRef
4. Lipid Regulatory Proteins as Potential Therapeutic Targets for Ovarian Cancer in Obese Women
   Jing Yang et al, 2020, Cancers CrossRef
5. Circadian clock and lipid metabolism disorders: a potential therapeutic strategy for cancer
   Mengsi Liu et al, 2023, Frontiers in Endocrinology CrossRef
6. SREBP-1 is an independent prognostic marker and promotes invasion and migration in breast cancer
   Jisheng Bao et al, 2016, Oncology Letters CrossRef
7. Upregulation of PD-L1 expression promotes epithelial-to-mesenchymal transition in sorafenib-resistant hepatocellular carcinoma cells
   Gui-Li Xu et al, 2020, Gastroenterology Report CrossRef
8. Role of cystathionine beta synthase in lipid metabolism in ovarian cancer
   Prabir K. Chakraborty et al, 2015, Oncotarget CrossRef
9. SIRT1 promotes endometrial tumor growth by targeting SREBP1 and lipogenesis
   LI LIN et al, 2014, Oncology Reports CrossRef
10. Schisandrin treatment suppresses the proliferation, migration, invasion, and inflammatory responses of fibroblast-like synoviocytes from rheumatoid arthritis patients and attenuates synovial inflammation and joint destruction in CIA mice
    Wei Lin et al, 2023, International Immunopharmacology CrossRef
11. Impact of silencing hepatic SREBP-1 on insulin signaling
    Victoria Jideonwo et al, 2018, PLOS ONE CrossRef
12. SREBP1 silencing inhibits the proliferation and motility of human esophageal squamous carcinoma cells via the Wnt/β‑catenin signaling pathway
    Jingzhi Wang et al, 2020, Oncology Letters CrossRef
13. Disruption of Cancer Metabolic SREBP1/miR-142-5p Suppresses Epithelial–Mesenchymal Transition and Stemness in Esophageal Carcinoma
    Chih-Ming Huang et al, 2019, Cells CrossRef
14. Arginine Methylation of SREBP1a via PRMT5 Promotes De Novo Lipogenesis and Tumor Growth
    Liu Liu et al, 2016, Cancer Research CrossRef
15. A Novel Synthesized Cyclohexane-Hydroxytyrosol Derivative Suppresses Ovarian Cancer Cell Growth Through Inducing Reactive Oxidative Species and Blocking Autophagic Flux
    Guanfei Zhang et al, 2024, Antioxidants & Redox Signaling CrossRef
16. SREBP-1 upregulates lipophagy to maintain cholesterol homeostasis in brain tumor cells
    Feng Geng et al, 2023, Cell Reports CrossRef
17. Unfolded protein response is involved in the metabolic and apoptotic regulation of oral squamous cell carcinoma
    B. Seo et al, 2022, Pathology CrossRef
18. Integrative multi-omic analysis identifies genetically influenced DNA methylation biomarkers for breast and prostate cancers
    Anita Sathyanarayanan et al, 2022, Communications Biology CrossRef
19. Ganoderma tsugae Inhibits the SREBP-1/AR Axis Leading to Suppression of Cell Growth and Activation of Apoptosis in Prostate Cancer Cells
    Shih-Yin Huang et al, 2018, Molecules CrossRef
20. Targeting lipid metabolism in the treatment of ovarian cancer
    Saliha Chaudhry et al, 2022, Oncotarget CrossRef
21. A computational framework for complex disease stratification from multiple large-scale datasets
    null null et al, 2018, BMC Systems Biology CrossRef
22. Significance and Application of Digital Breast Tomosynthesis for the BI-RADS Classification of Breast Cancer
    Si-Qing Cai et al, 2015, Asian Pacific Journal of Cancer Prevention CrossRef
23. SREBP1, targeted by miR-18a-5p, modulates epithelial-mesenchymal transition in breast cancer via forming a co-repressor complex with Snail and HDAC1/2
    Ning Zhang et al, 2019, Cell Death & Differentiation CrossRef
24. Distinct cholesterogenic and lipidogenic gene expression patterns in ovarian cancer - a new pool of biomarkers
    Georgios Pampalakis et al, 2015, Genes & Cancer CrossRef
25. Novel MicroRNA-Regulated Transcript Networks Are Associated with Chemotherapy Response in Ovarian Cancer
    Danai G. Topouza et al, 2022, International Journal of Molecular Sciences CrossRef
26. Screening of potential targets and small-molecule drugs related to lipid metabolism in ovarian cancer based on bioinformatics
    Xingfen Wang et al, 2024, Biochemical and Biophysical Research Communications CrossRef
27. Light chain 3 immunoexpression in psoriasis
    Rehab M. Samaka et al, 2022, Journal of Immunoassay and Immunochemistry CrossRef
28. Downregulation of SREBP inhibits tumor growth and initiation by altering cellular metabolism in colon cancer
    Yang-An Wen et al, 2018, Cell Death & Disease CrossRef
29. Targeting SREBP-1-Mediated Lipogenesis as Potential Strategies for Cancer
    Qiushi Zhao et al, 2022, Frontiers in Oncology CrossRef
30. Lipoproteins and cancer: The role of HDL-C, LDL-C, and cholesterol-lowering drugs
    Kush K. Patel et al, 2022, Biochemical Pharmacology CrossRef
31. SREBP-1 Has a Prognostic Role and Contributes to Invasion and Metastasis in Human Hepatocellular Carcinoma
    Chao Li et al, 2014, International Journal of Molecular Sciences CrossRef
32. Stearoyl coenzyme A desaturase
    Marin Abraham et al, 2018, Translational Research in Oral Oncology CrossRef
33. SREBP1 as a potential biomarker predicts levothyroxine efficacy of differentiated thyroid cancer
    Cuilin Li et al, 2020, Biomedicine & Pharmacotherapy CrossRef
34. Yarrow supercritical extract exerts antitumoral properties by targeting lipid metabolism in pancreatic cancer
    Lamia Mouhid et al, 2019, PLOS ONE CrossRef
35. Targeting endogenous fatty acid synthesis stimulates the migration of ovarian cancer cells to adipocytes and promotes the transport of fatty acids from adipocytes to cancer cells
    Thomas Grunt et al, 2024, International Journal of Oncology CrossRef
36. Antitumoral Effects of Metformin in Ovarian Cancer
    Maritza P. Garrido et al, 2019, Metformin [Working Title] CrossRef
37. Multi-Omic Approaches to Breast Cancer Metabolic Phenotyping: Applications in Diagnosis, Prognosis, and the Development of Novel Treatments
    Nuria Gómez-Cebrián et al, 2021, Cancers CrossRef
38. Oxysterols synergize with statins by inhibiting SREBP-2 in ovarian cancer cells
    Cinzia Casella et al, 2014, Gynecologic Oncology CrossRef
39. Cancer’s camouflage: Microvesicle shedding from cholesterol-rich tumor plasma membranes might blindfold first-responder immunosurveillance strategies
    Peter S. Coleman et al, 2022, European Journal of Cell Biology CrossRef
40. ACSL4 reprograms fatty acid metabolism in hepatocellular carcinoma via c-Myc/SREBP1 pathway
    Junru Chen et al, 2021, Cancer Letters CrossRef
41. High glucose microenvironment accelerates tumor growth via SREBP1-autophagy axis in pancreatic cancer
    Cancan Zhou et al, 2019, Journal of Experimental & Clinical Cancer Research CrossRef
42. TRPV4 enhances the synthesis of fatty acids to drive the progression of ovarian cancer through the calcium-mTORC1/SREBP1 signaling pathway
    Lan Lin et al, 2023, iScience CrossRef